Mirae Asset Global Etfs Holdings Ltd. Adaptive Biotechnologies Corp Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 68,830 shares of ADPT stock, worth $679,352. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68,830
Previous 65,916
4.42%
Holding current value
$679,352
Previous $395,000
29.37%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ADPT
# of Institutions
246Shares Held
156MCall Options Held
44.3KPut Options Held
47.8K-
Viking Global Investors LP30MShares$296 Million0.74% of portfolio
-
Rubric Capital Management LP New York, NY13.1MShares$129 Million2.79% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$115 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$110 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.73MShares$76.3 Million0.62% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.41B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...